Sahar Khorasani

478 citations
8 papers · 294 indexed · 1 hit paper · h-index 7
Topics
SARS-CoV-2 and COVID-19 Research (2 papers)Heparin-Induced Thrombocytopenia and Thrombosis (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)
Journals
SHILAP Revista de lepidopterologíaJournal of Cellular PhysiologyJournal of Cellular Biochemistry
Partner nations
IranGermanyPoland

In The Last Decade

Sahar Khorasani

8 papers receiving 290 citations

Hit Papers

Recent advances in non-small cell lung cancer targeted th...2023202620242025202350100150

Peers

Sahar Khorasani
Comparison fields: 5 of 68
  • Molecular Biology 122
  • Oncology 72
  • Pulmonary and Respiratory Medicine 68
  • Immunology 66
  • Cancer Research 44
Replace Xinwei Xu with:
Xinwei Xu China
Chengxin Luo China
Shailaja Sopory India
Wojciech Kielan Poland
Ge Yan China
S. D’Alò Italy
Zhehui Zhu China
Jarosław Suchański Poland
Erin E. Witalison United States
Sahar Khorasani relative to Xinwei Xu China Xinwei Xu's profile →
Citations per field
00.5×3.0×
Xinwei Xu · 1×
Citations per year

Countries citing papers authored by Sahar Khorasani

Since Specialization
Citations

This map shows the geographic impact of Sahar Khorasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahar Khorasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahar Khorasani more than expected).

Fields of papers citing papers by Sahar Khorasani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahar Khorasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahar Khorasani. The network helps show where Sahar Khorasani may publish in the future.

Co-authorship network of co-authors of Sahar Khorasani

This figure shows the co-authorship network connecting the top 25 collaborators of Sahar Khorasani. A scholar is included among the top collaborators of Sahar Khorasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahar Khorasani. Sahar Khorasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1
Recent advances in non-small cell lung cancer targeted therapy; an update reviewbreakdown →
150
2 7
3 6
4 16
5 2
6 52
7 13
8 48

About Sahar Khorasani

Sahar Khorasani is a scholar working on Immunology, Oncology and Infectious Diseases, having authored 8 papers that have together received 294 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology (66 citations), Gastroenterology (17 citations) and Cancer Research (44 citations). Sahar Khorasani has collaborated with scholars based in Iran, Germany and Poland. Frequent co-authors include Fatemeh Mardani, Reza Akhavan‐Sigari, Mina Alimohammadi, Seyed‐Alireza Esmaeili, Nafiseh Tabasi, Maryam Rastin, Mahmoud Mahmoudi, Fatemeh Faramarzi, Safa Tahmasebi and Samaneh Rostami. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026